Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
15103
Title:
Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder
Fulltext:
View PDF
Author
Gorman DA, Gardner DM, Murphy AL, Feldman M, Bélanger SA, Steele MM, et al
Publication/Review date:
2015-Feb 
Producers:
Canadian Consensus Group on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents
Endorsers:
Canadian Academy of Child and Adolescent Psychiatry
Canadian Paediatric Society
Fund Source:
Hospital for Sick Children Foundation
Royal Bank of Canada Knowledge Translation Fund

Bibliographic Source

Journal Citation:
Can J Psychiatry 2015;60(2):62-76.
Pages/Size:
15  Page(s)
References:
102
Notes:
Access to the full text content is limited to CMA members only

Subject Information

Specialties:
Clinical pharmacology, Psychiatry,
Conditions:
Attention Deficit Hyperactivity Disorder (ADHD); Conduct Disorder; Oppositional Defiant Disorder;
Domains:
Treatment
Target Populations:
Child, Adolescent
Target Gender:
Unknown
MeSH:
Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child Behavior; Adolescent Behavior; Conduct Disorder;

Copyright:

The copyright of this guideline and its companion documents belongs to: Canadian Psychiatric Association

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​